18327816

Source:http://linkedlifedata.com/resource/pubmed/id/18327816

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011065, umls-concept:C0025266, umls-concept:C0035647, umls-concept:C0039601, umls-concept:C0279025, umls-concept:C0301625, umls-concept:C0332293, umls-concept:C0376358, umls-concept:C0439231, umls-concept:C0851346, umls-concept:C2926735
pubmed:issue	10
pubmed:dateCreated	2008-5-5
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18327816-17828774
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0008-543X
pubmed:author	pubmed-author:PalmaDavidD, pubmed-author:PicklesTomT
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	112
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2322-3; author reply 2323
pubmed:meshHeading	pubmed-meshheading:18327816-Androgen Antagonists, pubmed-meshheading:18327816-Antineoplastic Agents, Hormonal, pubmed-meshheading:18327816-Combined Modality Therapy, pubmed-meshheading:18327816-Humans, pubmed-meshheading:18327816-Male, pubmed-meshheading:18327816-Prognosis, pubmed-meshheading:18327816-Prostatic Neoplasms, pubmed-meshheading:18327816-Radiotherapy, Intensity-Modulated, pubmed-meshheading:18327816-Risk Factors, pubmed-meshheading:18327816-Time Factors, pubmed-meshheading:18327816-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy.
pubmed:publicationType	Letter, Comment